Mesoblast implants two with adult stem cells
Monday, 06 February, 2006
The first two patients in Melbourne-based Mesoblast's (ASX:MSB) clinical trials have been implanted with adult stem cells.
"The procedure went well and both patients have been discharged from hospital," said principal investigator Dr Suku Thambar, an interventional cardiologist from the Hunter Medical Research Institute, in a statement. "We will closely monitor the patients' progress and look forward to seeing evidence of clinical improvement in a short period of time."
The trial, for the treatment of cardiovascular disease, is one of two currently being conducted in Australia to test the safety of Mesoblast's proprietary adult stem cell technology in humans. The other is for the repair of large bone fractures, and is being done at the Royal Melbourne Hospital.
Mesoblast's shares were up $0.07 to $1.37, more than 5 per cent, at press time.
Unhealthy Western diet could accelerate cognitive decline
An unhealthy Western-style diet is associated with a faster cognitive decline in people with a...
Cancer drug enters clinical trials based on a false mechanism
A cancer drug currently being tested in patients appears to have entered clinical trials based on...
Russia insists there is "no plague case" following lab worker death
Russian health authorities say there is no evidence that pneumonic plague played a part in the...
